The official Israeli drug policy greatly corresponds to
that of the United States. As is the case with other conservative governments,
Israeli policy is characterized by an
official "zero tolerance" with marijuana defined as a Schedule I drug.
The result of such a policy, which is evident in
any conservative establishment, is that the actual messages
that go out to the public are a mixture of semi-truths, lies,
and myths as well as utter policy mistakes even when the
truth is involved.
Thus, heads of the Anti-Drug Authority (ADA) are
noted to have said: "...but alcohol and nicotine are not
drugs..." (Mr. Haim Messing, Executive Director of the ADA, on a radio
debate in November 2002); the chief
scientist of the authority, Dr. Rachel
Bar-Hamburger, gave, on public
radio, a recipe for making Datura tea,
and just last week the ADA's website gave a detailed price list of the
major illicit drugs throughout the
country.
On the bright side, the courts and
the legal system, which are required
to deal with the "criminals" using
drugs, are displaying a remarkably
practical approach. Unlike the US where prison space is
not a problem, no such "luxury" is currently available in
Israel (though initial attempts to privatize prisons are
already underway). The Israeli judicial system cannot
offer space for pot or other drug users, or even small-time
growers, and alternatives are constantly being sought. At
the same time, judges are begging, and in certain cases,
instructing public prosecutors to "consider whether it is
appropriate to submit criminal charges against offenders
without a criminal record, where simple possession is
involved, so as to clear the court's diary for more serious
cases..." (Justice Moshe Alter, Acco Magistrates Court,
December 2004). In addition, just before his appointment
to the Supreme Court, former Attorney General, Elyakim
Rubinstein, issued official guidelines for first time offenders
of cannabis use. These guidelines give the option of
writing an "administrative warning" in an offender's criminal
record instead of criminal proceedings. This does not,
however, solve the problem of what happens to offenders
on subsequent occasions, when according to the guidelines,
this warning should be taken into consideration and thus
exacerbates the next judgment against the offender.
We can easily see the establishment's confusion and
inability to put forward a coherent and comprehensive
drug policy. This failure has a dire effect on drug use and
abuse and is demonstrated by a steady increase in drug
use spanning all ages in Israel. Naturally, this use/misuse
is not accompanied by any form of reliable information,
which aggravates the dangers inherent in uninformed use
of drugs.
The emergence of the Green Leaf Party, which actively
promotes legalization of cannabis and a change of drug policy to
harm reduction, combined with the
adoption of this point of view by a
number of members of the Israeli
Knesset (equivalent to Congress),
has had a positive effect on the
public debate. Harm reduction is
being openly discussed. A Harm
Reduction Forum has been formed
by MK Roman Bronfman of the
Democratic Choice Party, with
notable members such as Dr. Rafael
Mechoulam, Dr. Stanley Einstein, Dr. Hanan Frank, Dr.
Yossef Agasi, Mr. Boaz Wachtel and others. This forum,
with the substantial academic clout provided by its members,
is putting forward documents of a new nature. Of
special note is a booklet reviewing nine drugs, following
the DanceSafe model, which is being examined by the Tel
Aviv Municipal Anti-Drug Office, headed by a progressive
official, Mr. Benny Avrahami. It is hoped that this may be
the first cooperation between the forum with the "establishment."
Another paper, on heroin-related policy, has
also been prepared by the forum.
After a productive meeting with Anti-Drug Authority officials, MAPS researchers and staff
stop to mark the moment.
From the left: John Halpern, M.D., Rick Doblin, Ph.D., Michael Mithoefer, M.D., June May Ruse, Psy.D., and Jose Carlos Bouso.
Photo courtesy of John Halpern.
The treatment of heroin addicts suffers from a similarly
confused and incoherent policy. Several months ago, at
the request of a property owner, the Tel Aviv municipality
together with extensive police force "deported" 120 heroin
addicts from their south Tel-Aviv squat in a sad display of
wasted public funds. Yet even as this was done, it was fully
accepted by nearly all parties, that upon being dropped off
in one of four destinations throughout Israel, they would
all restart their journey back to the big city. This assumption
was later confirmed by a number of social workers. It
is interesting to point out that conversations with the ADA
revealed that there was no federal support for this action.
It would appear that with hard drugs, such as heroin, ADA
has acknowledged the inevitable - that drug use has to
be treated, at most, as an illness, and that the criminal
justice system has nothing
to contribute to this end.
This more enlightened
approach sadly still stands
in stark contrast with their
approach to "party drugs"
or cannabis.
I would conclude that
the Israeli prohibition
ethos on drug use, misuse,
and abuse fails time and
time again to get a clear
and comprehensive message across. The messages that are put forward span from
ridiculous (such as the TV ad campaign that showed a joint
turning into a syringe) to outright stupid and, from the
ADA's point of view, counterproductive (showing people
laughing and dancing at a rave and then warning about
the dangers of ecstasy use).
When the author has requested to inform young Israelis
traveling to the Far East and South America (where drug
experimentation is the norm for young travelers) of the
methods to reduce the harm associated with use of LSD,
ecstasy, psilocybin, and other substances, the response
from government officials has been "but if we do that then
we condone the use..."
In conclusion, Israel is not the place where great hope
for the progressive drug policy movement can be expected.
However, the existence of a public debate is noteworthy.
Legitimacy for a view opposing that of the establishment
is slowly gaining ground and will undoubtedly have an
impact on the future of drug policy in Israel.
Dan Goldenblatt is a political advisor to MK Roman Bronfman.
He held the number two position in the Green Leaf Party
list for the 2003 elections.
|
| Spring 2010 |
Vol. 20, No. 1 |
Special Edition: Psychedelics, Death and Dying |
| Autumn 2009 |
Vol. 19, No. 3 |
MAPS Financial Report: Fiscal Year 2008-09 |
| Summer 2009 |
Vol. 19, No. 2 |
MAPS Research Update 2009 |
| Spring 2009 |
Vol. 19, No. 1 |
Special Edition: Psychedelics and Ecology |
| Winter 2008/09 |
Vol. 18, No. 3 |
MAPS 2008 Financial Report |
| Summer 2008 |
Vol. 18, No. 2 |
Phoenix Rising: A Review of MAPS Research |
| Spring 2008 |
Vol. 18, No. 1 |
Special Edition: Technology and Psychedelics |
| Winter 2007 |
Vol. 17, No. 3 |
MAPS 06-07 Fiscal Yearly Report |
| Autumn 2007 |
Vol. 17, No. 2 |
Special Edition: Psychedelics and Self-Discovery |
| Spring/Summer 2007 |
Vol. 17, No. 1 |
The Chrysalis Stage |
| Winter 2006-7 |
Vol. 16, No. 3 |
Low Maintenance/High Performance |
| Autumn 2006 |
Vol. 16, No. 2 |
Technologies of Healing |
| Spring 2006 |
Vol. 16, No. 1 |
MAPS' 20th Anniversary |
| Winter 2005 |
Vol. 15, No. 3 |
MAPS final year as a teenager |
| Summer 2005 |
Vol. 15, No. 2 |
Israel Conference: MDMA/PTSD Research |
| Spring 2005 |
Vol. 15, No. 1 |
Accelerating flow of work and time |
| Autumn 2004 |
Vol. 14, No. 2 |
Rites of Passage: Kids and Psychedelics |
| Summer 2004 |
Vol. 14, No. 1 |
10 stamps and $250,000 |
| Winter 2003 |
Vol. 13, No. 2 |
Holy Fire |
| Spring 2003 |
Vol. 13, No. 1 |
60th Anniversary of the Discovery
of LSD |
| Autumn 2002 |
Vol. 12, No. 3 |
Vision |
| Summer 2002 |
Vol. 12, No. 2 |
"From celebration to frustration,
and back again." |
| Spring 2002 |
Vol. 12, No. 1 |
Sex, Spirit & Psychedelics 2002 |
| Autumn 2001 |
Vol. 11, No. 2 |
"In the future, it will be called
Despair." |
| Spring 2001 |
Vol. 11, No. 1 |
"A Tidal Wave of Ecstasy!" |
| Autumn 2000 |
Vol. 10, No. 3 |
Creativity 2000 |
| Summer 2000 |
Vol. 10, No. 2 |
Endings and Beginnings |
| Spring 2000 |
Vol. 10, No. 1 |
Making History in Slow Motion |
| Winter 1999/00 |
Vol. 9, No. 4 |
To the Ends of the Earth for MDMA
Research... |
| Autumn 1999 |
Vol. 9, No. 3 |
MAPS' long-standing efforts to conduct... |
| Summer 1999 |
Vol. 9, No. 2 |
MAPS has come full circle... |
| Spring 1999 |
Vol. 9, No. 1 |
Patience, persistence and passion |
| Winter 1998/99 |
Vol. 8, No. 4 |
One of special pleasures of directing
MAPS... |
| Autumn 1998 |
Vol. 8, No. 3 |
The Ayahuasca Issue (with Hofmann
interview) |
| Summer 1998 |
Vol. 8, No. 2 |
Emotionally Powerful Anecdotes... |
| Spring 1998 |
Vol. 8, No. 1 |
Death Has a Way of Focusing One's
Attention |
| Autumn 1997 |
Vol. 7, No. 4 |
Celebration is in Order |
| Summer 1997 |
Vol. 7, No. 3 |
Time Horizons |
| Spring 1997 |
Vol. 7, No. 2 |
Synchronicity |
| Winter 1996/97 |
Vol. 7, No. 1 |
Learning to Crawl |
| Autumn 1996 |
Vol. 6, No. 4 |
An Invitation for Dialogue |
| Summer 1996 |
Vol. 6, No. 3 |
Budding Research |
| New Year 1996 |
Vol. 6, No. 2 |
Sending Down Roots |
| Autumn 1995 |
Vol. 6, No. 1 |
Baby Steps |
| Summer 1995 |
Vol. 5, No. 4 |
Opportunity Amidst Obstacles |
| Winter 1994/95 |
Vol. 5, No. 3 |
Clinical Trials and Tribulations |
| Autumn 1994 |
Vol. 5, No. 2 |
Building Towards Clinical Trials |
| Summer 1994 |
Vol. 5, No. 1 |
Politics and Protocols: In Search
of a Balance |
| Spring 1994 |
Vol. 4, No. 4 |
Laying the Groundwork |
| Winter 1993/94 |
Vol. 4, No. 3 |
A Time of Tests |
| Summer 1993 |
Vol. 4, No. 2 |
So Close Yet So Far |
| Spring 1993 |
Vol. 4, No. 1 |
Remembrance and Renewal |
| Winter 1992/93 |
Vol. 3, No. 4 |
Forging New Alliances |
| Summer 1992 |
Vol. 3, No. 3 |
Building on Common Ground |
| Spring 1992 |
Vol. 3, No. 2 |
Small Steps, Gradual Progress, New
Opportunities |
| Winter 1991/92 |
Vol. 3, No. 1 |
The Rekindling of a Thousand Points
of Light |
| Summer 1991 |
Vol. 2, No. 2 |
MDMA protocol development with cancer patients |
| Winter 1990/91 |
Vol. 2, No. 1 |
MAPS' Swiss pharmacologically-assisted psychotherapy
conference |
| Autumn 1990 |
Vol. 1, No. 3 |
What and Who is MAPS? |
| Summer 1989 |
Vol. 1, No. 2 |
Switzerland Leads the Way |
| Summer 1988 |
Vol. 1, No. 1 |
MDMA can become a legal medicine |
|
|